You React to Everything?! The 200 Causes Largely Missed.

EXCERPT FROM OUR 1250 PAGE EBOOK. THIS EXISTS NO OTHER PLACE I KNOW.

There are several different types of sensitivity. They are not all allergies, and they do not all involve toxins.

For example:

• True allergy: The immune system reacts to a substance.
• Irritation: A chemical directly stimulates the nose, eyes, skin, or airways.
• Nerve sensitivity: The brain or sensory nerves respond strongly to smells or chemical exposure.
• Drug intolerance: A patient experiences side effects at ordinary or unusually low doses.
• Poor drug processing: A genetic difference, illness, or drug interaction changes how much medication remains in the body.
• Conditioned sensitivity: The nervous system learns to associate a smell or exposure with symptoms. The resulting symptoms can be physically real.

A patient can have more than one of these problems at the same time.

The following 200 entries are possible causes, contributing factors, mechanisms, and clinical associations promoting large reactivity.

I will number the explanations and match them to full scientific references at the end. Where one paper supports several points, that paper may appear more than once.

Part 1. Nose, Sinuses, and Breathing Problems (1–25)

1. Allergic rhinitis: Allergies inflame the nose, making exposure to irritating odors harder to tolerate.
2. Nonallergic rhinitis: The nose reacts to perfume, temperature changes, smoke, or fumes without a true allergy.
3. Vasomotor rhinitis: Sensitive nasal nerves cause congestion, sneezing, or a runny nose.
4. Chronic sinusitis: Long-term sinus inflammation may increase discomfort from airborne irritants.
5. Nasal polyps: Swollen tissue changes airflow and smell perception.
6. Asthma: Perfume or chemical fumes may trigger coughing, wheezing, and chest tightness.
7. Poorly controlled asthma: Already inflamed airways may respond more strongly to irritants.
8. Occupational asthma: Repeated exposure to workplace chemicals may cause asthma.
9. Reactive airways dysfunction syndrome: A major irritant exposure can cause lasting asthma-like symptoms.
10. Exercise-induced bronchoconstriction: Exercise may add to existing airway sensitivity.
11. Eosinophilic airway inflammation: Certain immune cells increase airway inflammation.
12. Chronic bronchitis: Inflamed bronchial tubes can be irritated by smoke and fumes.
13. COPD: Damaged airways may be more vulnerable to polluted air.
14. Bronchiectasis: Damaged, widened airways can produce chronic cough and irritation.
15. Vocal cord dysfunction: The vocal cords may partly close during exposure to strong odors.
16. Inducible laryngeal obstruction: Irritants can trigger temporary narrowing around the voice box.
17. Laryngeal hypersensitivity: Sensitive throat nerves may cause coughing or choking sensations.
18. Chronic cough hypersensitivity: The cough reflex becomes unusually easy to trigger.
19. Postviral airway sensitivity: Breathing passages may remain sensitive after respiratory infections.
20. Reflux-related throat irritation: Stomach acid reaching the throat may increase coughing.
21. Dry nasal membranes: Dry tissue may burn when exposed to chemicals.
22. Damaged nasal lining: Prior chemical exposure may make the nose more easily irritated.
23. Trigeminal nerve sensitivity: Irritating chemicals stimulate facial sensory nerves, even without an allergy.
24. High sensitivity to airborne particles: Dust and particles may worsen existing airway inflammation.
25. Work-related rhinitis: Workplace chemicals, powders, and fumes may repeatedly inflame the nose.

Part 2. Brain and Nervous System (26–50)

26. Migraine: Perfumes and odors can trigger severe headaches in susceptible patients.
27. Osmophobia: A patient has unusually strong discomfort from smells, commonly with migraine.
28. Hyperosmia: A person experiences smells as unusually intense.
29. Parosmia: Normal odors smell distorted, unpleasant, or strange.
30. Phantosmia: A patient smells something when no matching odor source is present.
31. Postviral smell dysfunction: Infections can change how the brain interprets odors.
32. Post-COVID smell disturbance: COVID-19 can leave lasting smell abnormalities.
33. Central sensitization: The nervous system responds more strongly to ordinary sensory input.
34. Sensory processing differences: The brain has difficulty filtering certain sensory signals.
35. Trigeminal sensitization: Facial nerves become more reactive to irritating chemicals.
36. Chronic migraine: Repeated migraines may increase sensitivity between attacks.
37. Vestibular migraine: Odors may accompany or trigger dizziness and migraine symptoms.
38. Post-concussion syndrome: Some patients develop intolerance to light, sound, and other sensory input.
39. Traumatic brain injury: Brain injury can change sensory processing.
40. Autonomic nervous system dysfunction: Automatic control of heart rate, sweating, and blood pressure may be unstable.
41. Postural orthostatic tachycardia syndrome: Patients may experience dizziness and rapid heartbeat during symptomatic episodes; odors are not an established direct cause.
42. Small-fiber neuropathy: Damage to small nerves may alter pain and automatic body functions.
43. Peripheral nerve sensitization: Irritating chemicals may produce stronger-than-normal sensations.
44. Chronic neuropathic pain: A highly reactive nervous system may also have other sensory sensitivities.
45. Fibromyalgia: Some patients report increased sensitivity to smells and other sensory experiences.
46. Chronic widespread pain: Sensory amplification may occur alongside persistent pain.
47. Sleep deprivation: Poor sleep can increase pain, headache, and sensory discomfort.
48. Circadian rhythm disruption: Irregular sleep timing can worsen migraines and symptom tolerance.
49. Sensory overload: Several ordinary sensory signals together may become overwhelming.
50. Altered brain processing of odors: Research suggests that some patients with chemical intolerance process sensory information differently.

Part 3. Immune System, Allergy, and Inflammation (51–75)

51. IgE-mediated allergy: Certain substances can cause immediate allergic reactions.
52. Allergic contact dermatitis: Fragrance ingredients can cause delayed skin inflammation.
53. Fragrance mix allergy: Patients may react to several fragrance ingredients detected by patch testing.
54. Balsam of Peru allergy: Certain fragrance-related chemicals can trigger contact allergy.
55. Preservative allergy: Preservatives in cosmetics or medications may cause skin reactions.
56. Formaldehyde allergy: Formaldehyde-containing products can cause allergic contact dermatitis.
57. Isothiazolinone allergy: Preservatives such as methylisothiazolinone can cause severe skin reactions.
58. Latex allergy: Latex proteins can cause immediate allergic symptoms.
59. Atopic dermatitis: Damaged skin barriers allow irritants to cause more discomfort.
60. Chronic urticaria: Patients develop recurring hives, sometimes worsened by nonspecific triggers.
61. Physical urticaria: Heat, cold, pressure, or friction can produce hives.
62. Mast cell activation syndrome: Documented episodes of mast-cell mediator release can cause flushing, hives, and other symptoms.
63. Systemic mastocytosis: Excess abnormal mast cells can cause repeated allergic-type reactions.
64. Hereditary alpha-tryptasemia: A genetic trait associated with higher tryptase levels and, in some patients, mediator-related symptoms.
65. Histamine intolerance: A proposed explanation for symptoms after histamine-rich foods; diagnostic standards remain uncertain.
66. Chronic allergic inflammation: Existing inflammation may make tissues less comfortable during exposure.
67. Eosinophilic esophagitis: Allergic inflammation of the esophagus may contribute to food-related reactions, not usually odor reactions.
68. Eosinophilic gastrointestinal disease: Certain immune conditions can cause strong food-related symptoms.
69. Drug-induced immune reactions: Some medicines activate the immune system and cause genuine hypersensitivity.
70. Non-IgE mast-cell activation: Certain drugs can directly activate mast cells without a classic allergy.
71. Complement activation: Some injected medicines trigger inflammatory reactions through complement proteins.
72. Autoimmune disease: Active autoimmune inflammation may worsen overall symptoms, although it does not prove chemical intolerance.
73. Immune dysregulation after infection: Some patients develop prolonged immune-related symptoms after infections.
74. Inflammatory skin barrier damage: Irritants can enter damaged skin more easily.
75. Repeated allergen exposure: Continued exposure to a proven allergen can maintain inflammation.

Part 4. Medication Processing and Drug Reactions (76–110)

76. CYP2D6 poor metabolism: Certain drugs may remain in the body longer.
77. CYP2C19 poor metabolism: Some antidepressants and other medicines may reach higher levels.
78. CYP2C9 reduced metabolism: Certain medicines may cause greater toxicity at standard doses.
79. CYP3A4 drug interactions: One medicine may slow the breakdown of another.
80. CYP3A5 genetic variation: Some patients process specific drugs differently.
81. UGT1A1 reduced activity: Some medicines may accumulate or produce more toxicity.
82. UGT2B7 variation: Differences in drug conjugation may affect certain medicines.
83. NAT2 slow acetylation: Drugs such as isoniazid may produce more adverse effects.
84. TPMT deficiency: Thiopurine medicines can cause dangerous bone marrow suppression.
85. NUDT15 variants: Certain genetic variants increase thiopurine toxicity.
86. DPYD deficiency: Fluoropyrimidine cancer medicines can cause severe toxicity.
87. SLCO1B1 variants: Some patients have increased risk of statin-related muscle injury.
88. HLA-B*57:01: Strongly associated with abacavir hypersensitivity.
89. HLA-B*15:02: Increases risk of severe skin reactions to certain antiseizure medicines.
90. HLA-B*58:01: Increases risk of severe allopurinol hypersensitivity.
91. G6PD deficiency: Certain drugs can cause red blood cells to break down.
92. Reduced kidney function: Medicines cleared through the kidneys can accumulate.
93. Liver cirrhosis: Severe liver disease changes how many medicines are processed.
94. Acute hepatitis: Liver inflammation can temporarily change drug metabolism.
95. Low blood albumin: Some highly protein-bound medicines may have increased free drug levels.
96. Dehydration: Reduced circulating fluid and kidney function can worsen drug side effects.
97. Older age: Age-related changes in drug clearance may increase sensitivity.
98. Low body weight: Standard doses may be excessive for some smaller patients.
99. Drug-drug interactions: Two medicines can raise each other’s effects or toxicity.
100. Drug-herb interactions: Herbal products may change medication levels.
101. Grapefruit interactions: Grapefruit can increase blood levels of certain medicines.
102. Enzyme inhibition: A substance blocks an enzyme needed to remove a drug.
103. Enzyme induction: A substance increases drug breakdown and changes treatment effects.
104. P-glycoprotein transporter differences: Changes in drug transport can alter drug exposure.
105. Blood-brain barrier transport differences: Some drugs may enter or leave the brain differently.
106. Pharmacodynamic sensitivity: Normal drug concentrations produce unusually strong effects.
107. Opioid sensitivity: Some patients develop sedation or breathing problems at lower doses.
108. Benzodiazepine sensitivity: Some patients develop marked sedation, confusion, or falls.
109. Anticholinergic sensitivity: Certain medicines produce strong dry mouth, confusion, or urinary problems.
110. Excipients in medicines: Dyes, preservatives, or other inactive ingredients can occasionally cause reactions.

Part 5. Hormones, Metabolism, and Nutrition (111–135)

111. Thyroid hormone excess: Hyperthyroidism may increase palpitations, sweating, and nervous-system symptoms.
112. Thyroid hormone deficiency: Hypothyroidism may change drug clearance and cause fatigue.
113. Adrenal insufficiency: Low cortisol can cause weakness, low blood pressure, and illness-related vulnerability.
114. Cushing syndrome: Excess cortisol can affect sleep, mood, blood pressure, and glucose.
115. Menstrual migraine: Hormone changes may increase odor-triggered headaches.
116. Pregnancy-related smell changes: Some pregnant patients report greater odor aversion and nausea.
117. Menopause-related migraine changes: Hormonal shifts may change migraine frequency.
118. Estrogen fluctuations: Changes in estrogen can influence migraine susceptibility.
119. Progesterone-related drug effects: Hormonal changes may alter responses to certain medications.
120. Hypoglycemia: Low blood sugar can produce sweating, trembling, and palpitations that resemble a reaction.
121. Diabetes-related autonomic neuropathy: Nerve damage can affect heart rate, blood pressure, and digestion.
122. Severe anemia: Reduced oxygen delivery may cause dizziness and breathlessness.
123. Iron deficiency: Can cause fatigue, headaches, and reduced physical tolerance.
124. Vitamin B12 deficiency: May cause neuropathy and neurological symptoms.
125. Thiamine deficiency: Severe deficiency can damage nerves and the brain.
126. Magnesium deficiency: May contribute to muscle symptoms and abnormal heart rhythms.
127. Calcium imbalance: Abnormal calcium can affect nerves and muscles.
128. Sodium imbalance: Abnormal sodium can cause headaches, confusion, or weakness.
129. Potassium imbalance: Can cause weakness and heart rhythm changes.
130. Malnutrition: Poor nutritional status can affect drug distribution and recovery.
131. Low protein intake: Severe deficiency may alter body composition and medication handling.
132. Severe vitamin D deficiency: Can contribute to muscle pain and weakness, not a proven cause of odor intolerance.
133. Obesity-related breathing problems: Reduced breathing reserve can worsen symptoms around airway irritants.
134. Deconditioning: Low physical fitness may worsen breathlessness and rapid heartbeat.
135. Metabolic acidosis: Serious acid-base disturbances can cause rapid breathing and weakness.

Part 6. Infections and Post-Infectious Illness (136–155)

These conditions can produce symptoms that overlap with chemical intolerance. For most infections below, evidence does not establish that the infection directly causes sensitivity to perfume or ordinary fumes.

136. Long COVID: May involve headaches, fatigue, autonomic problems, and smell disturbances.
137. Postviral fatigue syndromes: Persistent symptoms after infections may reduce overall tolerance of stressors.
138. ME/CFS: Some patients report sensory sensitivity alongside severe fatigue and post-exertional worsening.
139. Post-infectious migraine: Headaches may develop or worsen after an illness.
140. Post-infectious dysautonomia: Infection may be followed by heart rate or blood pressure regulation problems.
141. Chronic rhinosinusitis after infection: Ongoing nasal inflammation can increase irritant discomfort.
142. Postviral parosmia: Normal smells become distorted after viral illness.
143. Postviral phantosmia: Smell sensations occur without a matching odor source.
144. Persistent airway inflammation after infection: Airways may remain reactive for weeks or longer.
145. Post-infectious cough hypersensitivity: Mild odors may trigger coughing after an infection.
146. Lyme disease with neurological involvement: Can cause nerve symptoms, but direct perfume hypersensitivity is not established.
147. Post-treatment Lyme disease symptoms: Fatigue, pain, or cognitive complaints may persist; chemical intolerance is not a proven defining feature.
148. Bartonella infection with neurological complications: Neurological effects are possible, but a direct link to broad chemical sensitivity is unproven.
149. Babesiosis-related anemia: Can cause weakness and breathlessness, making additional physical stress harder to tolerate.
150. Babesiosis-related systemic illness: Severe infection may temporarily reduce physical reserve.
151. Influenza-related airway inflammation: May temporarily increase sensitivity to smoke or fumes.
152. RSV-related airway inflammation: Can cause wheezing and increased airway reactivity.
153. Pertussis-related prolonged cough: The cough reflex may remain sensitive after infection.
154. Post-infectious small-fiber neuropathy: Some patients develop sensory and autonomic symptoms following infection.
155. Post-infectious vestibular disorders: Dizziness may worsen with migraine or other sensory triggers.

Part 7. Environmental Exposures and Chemical Injury (156–180)

156. High-level solvent exposure: Certain solvents can damage the nervous system.
157. Repeated occupational solvent exposure: Long-term exposure may cause neurological or respiratory problems.
158. Pesticide poisoning: Certain pesticides can injure nerves or interfere with normal nerve signaling.
159. Organophosphate exposure: Significant exposure can inhibit acetylcholinesterase and cause serious illness.
160. Smoke inhalation injury: Smoke can inflame or damage airways.
161. Wildfire smoke exposure: Fine particles and gases may worsen asthma and breathing symptoms.
162. Tobacco smoke exposure: Smoke irritates airways and increases respiratory symptoms.
163. Secondhand smoke exposure: Can worsen asthma and airway inflammation.
164. Vaping aerosol exposure: May irritate the lungs and airways.
165. Nitrogen dioxide exposure: A respiratory irritant that can worsen asthma.
166. Ozone exposure: Can cause airway inflammation and reduced lung function.
167. Sulfur dioxide exposure: Can trigger bronchoconstriction in susceptible people.
168. Ammonia exposure: Irritates the eyes, nose, throat, and lungs.
169. Chlorine gas exposure: Can cause serious airway injury.
170. Bleach mixed with acid: May release chlorine gas and cause dangerous respiratory injury.
171. Bleach mixed with ammonia: Can produce irritating chloramine gases.
172. Formaldehyde exposure: Can irritate eyes and airways and cause contact allergy.
173. Paint solvent exposure: Can cause headaches, dizziness, or irritation at sufficient concentrations.
174. Fuel vapor exposure: Gasoline vapors can irritate airways and cause neurological symptoms at higher exposures.
175. Carbon monoxide exposure: Reduces oxygen delivery and can cause headache, dizziness, or death.
176. Hydrogen sulfide exposure: At dangerous concentrations, can cause severe respiratory and neurological injury.
177. Indoor dampness and mold: Damp buildings can worsen asthma and respiratory symptoms in susceptible people.
178. Dust mite exposure: Can worsen allergic asthma and rhinitis.
179. Cleaning-product aerosols: Sprays can irritate airways, especially in people with asthma.
180. Poor indoor ventilation: Allows indoor pollutants to build up and may increase exposure.

Part 8. Psychological, Sensory, and Other Contributors (181–200)

These mechanisms should not be used to dismiss patients. Symptoms can be severe and disabling even when routine medical tests are normal.

181. Post-traumatic stress disorder: Heightened threat responses may increase sensitivity to sensory cues.
182. Hypervigilance: The brain stays unusually alert to possible threats.
183. Conditioned odor responses: A smell linked with a previous illness or frightening event may later trigger symptoms.
184. Panic disorder: Physical symptoms such as breathlessness and palpitations may occur around perceived triggers.
185. Hyperventilation syndrome: Rapid breathing can cause dizziness, tingling, and chest discomfort.
186. Chronic stress: Can worsen migraines, sleep, pain, and autonomic symptoms.
187. Generalized anxiety disorder: Persistent worry can increase attention to uncomfortable body sensations.
188. Somatic symptom disorder: Severe physical distress can persist with excessive symptom-related worry; it does not rule out physical illness.
189. Functional neurological disorder: Changes in nervous-system functioning can produce genuine neurological symptoms.
190. Nocebo effects: Expectations of harm can increase symptoms or medication side effects.
191. Prior severe medication reaction: A previous frightening reaction can make future treatment more difficult to tolerate.
192. Medication withdrawal: Stopping certain medicines can cause dizziness, anxiety, sweating, or sensory symptoms.
193. Alcohol withdrawal: Can cause severe nervous-system overactivity and requires appropriate medical care.
194. Caffeine sensitivity: Small amounts can produce palpitations, anxiety, or insomnia in some people.
195. Nicotine sensitivity: Nicotine can produce nausea, dizziness, or a rapid heartbeat.
196. Motion sickness susceptibility: Some patients have greater nausea responses to sensory stimulation.
197. Persistent postural-perceptual dizziness: Visual motion and complex environments may worsen dizziness.
198. Autism-related sensory sensitivity: Some autistic people experience smells, sounds, or touch more intensely.
199. Idiopathic environmental intolerance: A clinical pattern of symptoms attributed to low-level exposures, with no single proven mechanism.
200. Several conditions occurring together: A patient may simultaneously have asthma, migraine, fragrance allergy, altered drug metabolism, and nervous-system sensitivity, producing a much stronger overall reaction.

Sample References

Below are verified research references for the main clinical mechanisms, with the relevant item numbers stated explicitly. They are not a fabricated 200-paper bibliography.

Reference 1 — Supports Items 26–35, 49–50, 181–190, 199–200

Binkley KE. Multiple Chemical Sensitivity/Idiopathic Environmental Intolerance: A Practical Approach to Diagnosis and Management. The Journal of Allergy and Clinical Immunology: In Practice. 2023;11(12):3645–3649. doi:10.1016/j.jaip.2023.08.039.

Reference 2 — Supports Items 28–35, 49–50, 181–183, 199–200

Jacques L. Multiple Chemical Sensitivity: A Clinical Perspective. Toxics. 2024. Full text available through the National Library of Medicine: Read the complete study.

Reference 3 — Supports Items 26–35, 49–50 and 199

Perspectives on multisensory perception disruption in idiopathic environmental intolerance: a systematic review. PubMed PMID: 30088144. Full bibliographic record.

Reference 4 — Supports Items 2–3, 23–25, 51–59, 156–174 and 179

Wise SK, et al. International consensus statement on allergy and rhinology: Allergic rhinitis – 2023. International Forum of Allergy & Rhinology. 2023. doi:10.1002/alr.23090.

Wiley Online Library

Reference 5 — Supports Items 6–9, 26, 160–168 and 179

Steinemann A. Fragranced consumer products: effects on asthmatics. Air Quality, Atmosphere & Health. 2018. PubMed PMID: 29391919. Full research article.

PMC

Reference 6 — Supports Items 26–35, 49–50 and 199

The role of sensory and olfactory pathways in multiple chemical sensitivity. Reviews on Environmental Health. 2020. doi:10.1515/reveh-2020-0058. PubMed PMID: 33070122.

PubMed

Reference 7 — Supports Items 181–183, 186, 190 and 199

Giardino ND, Lehrer PM. Behavioral conditioning and idiopathic environmental intolerance. Occupational Medicine. 2000;15(3):519–528. PubMed PMID: 10903547.

PubMed

Reference 8 — Supports Items 26–35, 49–50, 181–190 and 199

Chemical intolerance: involvement of brain function and networks after exposure to extrinsic stimuli perceived as hazardous. 2019. Full article: National Library of Medicine.

Reference 9 — Supports Items 26, 51–75 and 199

Italian Expert Consensus on Clinical and Therapeutic Management of Multiple Chemical Sensitivity (MCS). 2021. Full article: National Library of Medicine.

Reference 10 — Supports Items 26, 50 and 199–200

Steinemann A. National Prevalence and Effects of Multiple Chemical Sensitivities. Journal of Occupational and Environmental Medicine. 2018. doi:10.1097/JOM.0000000000001272.

Important Clinical Conclusions

For a patient who reacts to very small amounts of perfume, fumes, and multiple medications, the most useful first distinction is whether the episodes involve objective allergic findings, airway narrowing, migraine, neurological sensory symptoms, drug accumulation, or a combination of these.

A history of reactions to many unrelated medicines does not automatically establish multiple drug allergies. Likewise, strong symptoms from an odor do not automatically establish systemic poisoning.

When reactions include throat swelling, severe wheezing, fainting, or rapidly falling blood pressure, emergency evaluation is essential because anaphylaxis or serious airway disease may be present. And you should have an EPI-PEN available to you in a red carrier with word EPI-PEN on its outer surface.

The strongest starting areas for evaluation are allergy and respiratory disease, migraine and sensory processing, specific medication reactions, and genetic or organ-related problems with drug metabolism. Broad, unvalidated chemical-sensitivity testing should not replace targeted clinical assessment.

Evidence: The ten sources above support the central framework but do not individually validate all 200 entries.